Leenaars P P, Hendriksen C F, Koedam M A, Claassen I, Claassen E
National Institute of Public Health and Environmental Protection (RIVM), Bilthoven, The Netherlands.
Vet Immunol Immunopathol. 1995 Sep;48(1-2):123-38. doi: 10.1016/0165-2427(94)05413-m.
Four types of adjuvants were evaluated as alternatives to the use of Freund's complete adjuvant in mice. The adjuvants evaluated included a water-in-oil emulsion (Specol), a microorganism (Lactobacillus), performed immune-stimulating complexes (ISCOM) containing rabies virus glycoprotein and a saponin, Quil A. The adjuvants and saline were combined with three weak immunogens (a synthetic peptide, a self antigen and a particulate antigen) and given by three different routes (intraperitoneal, subcutaneous and dorsal in the foot). The evaluation was based on clinical observations, behavioural studies, pathological lesions and capacity to support immunological responses to weak immunogens. Lesions were most severe after injection of antigen combined with Freund's adjuvant or Quil A, mild to moderate with Specol and minimal with Lactobacillus, iscom conjugates or saline. Despite pathological changes, no signs of prolonged pain or distress could be demonstrated based on clinical observations and behavioural studies. Minimal immunological responses were found after injection of antigen in combination with saline or Lactobacillus. T-cell activation and high antibody responses were found after injection of antigen-iscom conjugates or antigen in Freund's adjuvant emulsions. After Specol/antigen immunisations T-cell activation was demonstrated and high antibody titres were found except for Specol/self antigen immunisations. Presented data suggest that Specol is a possible alternative to Freund's complete adjuvant for the induction of an immune response against weak immunogens except possibly self antigens, for which performed iscoms seem very suitable.
评估了四种佐剂作为小鼠中弗氏完全佐剂替代品的效果。所评估的佐剂包括油包水乳液(Specol)、一种微生物(乳酸杆菌)、含有狂犬病病毒糖蛋白的预制免疫刺激复合物(ISCOM)和一种皂苷(Quil A)。这些佐剂和生理盐水与三种弱免疫原(一种合成肽、一种自身抗原和一种颗粒抗原)混合,并通过三种不同途径给药(腹腔内、皮下和足部背侧)。评估基于临床观察、行为研究、病理损伤以及支持对弱免疫原产生免疫反应的能力。注射抗原与弗氏佐剂或Quil A联合后的损伤最严重,使用Specol时为轻度至中度,使用乳酸杆菌、ISCOM缀合物或生理盐水时损伤最小。尽管有病理变化,但基于临床观察和行为研究未发现长期疼痛或痛苦的迹象。注射抗原与生理盐水或乳酸杆菌联合后发现免疫反应最小。注射抗原-ISCOM缀合物或抗原与弗氏佐剂乳液后发现T细胞活化和高抗体反应。Specol/抗原免疫后证明有T细胞活化,除了Specol/自身抗原免疫外均发现高抗体滴度。所呈现的数据表明,对于诱导针对弱免疫原(可能自身抗原除外,预制ISCOM似乎对此非常合适)的免疫反应,Specol可能是弗氏完全佐剂的一种替代品。